Cozen O’Connor: Cozen O’Connor Strengthens Life Sciences Offerings with New Addition to Corporate Practice Group

Cozen O’Connor Strengthens Life Sciences Offerings with New Addition to Corporate Practice Group

Tuesday, July 11, 2017

Philadelphia, Pa., July 11, 2017 – Cozen O’Connor is pleased to welcome Melinda Rudolph to the firm as a member. Rudolph joins the firm’s Corporate Practice Group and is resident in the Philadelphia office.

Rudolph joins Cozen O’Connor from Reed Smith, where she handled domestic and multinational life sciences transactions as a member of the Life Sciences Health Industry Group. At Cozen O’Connor, she will continue to advise life science companies and service providers on commercial and operational issues, with a concentration in technology licensing and transactions.

“As life sciences clients continue to face new and increasingly nuanced issues, I am thrilled to join a firm as highly regarded in the industry as Cozen O’Connor,” said Rudolph. “I was attracted to the deep expertise and experience of the firm leadership and their strong commitment to high quality and innovative client service.”

Rudolph has represented companies in both private practice and as in-house counsel and has recently represented a clinical logistics services company in multinational pharmaceutical manufacturing, packaging and distribution services agreements, a pharmaceutical company in negotiations regarding in-licensing of biologic material and a start-up pharmaceutical company regarding license of technology platform. She has also served as general counsel of a publicly traded biotechnology company.

“Melinda’s wealth of life sciences experience will be an invaluable asset to our clients,” said Larry Laubach, chair of the Corporate Practice Group. “We are confident that she will play an integral role in expanding the firm’s ability to expertly service clients across the life sciences industry.”

Cozen O’Connor has expanded its offerings in the life science industry serving clients ranging from startups to global pharmaceutical companies, as well as venture capital and private equity firms focused on the life sciences industry.

Some of the firm’s recent hires include the additions of nationally recognized telemedicine attorney Rene Quashie, leading emerging growth attorney Jeremy Garvey and health policy adviser Allison Wils. Cozen O’Connor attorneys in the life sciences industry cut across many firm practice areas, including corporate, intellectual property, health law, labor & employment and litigation.

About Cozen O’Connor

Established in 1970 and ranked among the top 100 law firms in America, Cozen O’Connor has more than 700 attorneys who help clients manage risk and make better business decisions. The firm counsels clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. Representing a broad array of leading global corporations and middle market companies, Cozen O’Connor services its clients’ needs through 26 offices across two continents.

###